2001
Language regression in childhood.
Shinnar S, Rapin I, Arnold S, Tuchman R, Shulman L, Ballaban-Gil K, Maw M, Deuel R, Volkmar F. Language regression in childhood. Pediatric Neurology 2001, 24: 183-9. PMID: 11301218, DOI: 10.1016/s0887-8994(00)00266-6.Peer-Reviewed Original ResearchMeSH KeywordsBrainChildChild Behavior DisordersChild LanguageChild, PreschoolCognition DisordersElectroencephalographyFemaleHumansInfantLandau-Kleffner SyndromeLanguage DisordersLanguage TestsMagnetic Resonance ImagingMaleProspective StudiesRegression, PsychologySeverity of Illness IndexTomography, Emission-Computed, Single-PhotonVerbal BehaviorConceptsYears of ageLanguage regressionAutistic regressionMajor medical centersMonths of ageClinical characteristicsEpileptic aphasiaSpecialist referralMean ageElectroencephalogram abnormalitiesMedical CenterEarly identificationMost childrenSeizuresMean timeAutistic featuresAgeAutistic behaviorChildrenLanguage functionReferralMonthsRegressionPatientsYearsLanguage regression in childhood
Shinnar S, Rapin I, Arnold S, Tuchman R, Shulman L, Ballaban-Gil K, Maw M, Deuel R, Volkmar F. Language regression in childhood. Pediatric Neurology 2001, 24: 185-191. PMID: 32018934, DOI: 10.1016/s0887-8994(00)00266-6.Peer-Reviewed Original ResearchLanguage regressionAutistic regressionLandau-Kleffner syndromeLanguage functionEpileptic aphasiaAcquire languageCommunicative gesturesAutistic behaviorAutistic featuresYears of ageElectroencephalogram abnormalitiesMonths of ageChildrenLanguageEarly identificationAphasiaSeizuresAutismClinical characteristicsCognitionFollow-upMedical CenterBehaviorWordsChildhood
1996
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L. A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder. JAMA Psychiatry 1996, 53: 1001-1008. PMID: 8911223, DOI: 10.1001/archpsyc.1996.01830110037005.Peer-Reviewed Original ResearchConceptsStudy of FluvoxamineAutistic disorderSelective serotonin uptake inhibitorAdverse cardiovascular eventsPlacebo-controlled trialWeeks of treatmentSerotonin uptake inhibitorSerotonin neurotransmitter systemShort-term treatmentCardiovascular eventsPlacebo groupMild sedationNeurotransmitter systemsTreatment responseSafe drugUptake inhibitorFluvoxamineSymptoms of autismFluvoxamine maleateDisordersPlaceboAutistic behaviorPatientsAdultsSymptoms